National and international policies to mitigate disease threats

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 367, Issue 1604, 2012, Pages 2893-2900

  Dye, Christopher ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cholera; Drug resistance; HIV AIDS; International health regulations; Rabies; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHOLERA; DISEASE SEVERITY; DRUG RESISTANCE; HEALTH POLICY; HUMAN IMMUNODEFICIENCY VIRUS; INTELLECTUAL PROPERTY RIGHTS; OWNERSHIP; POLICY MAKING; PUBLIC HEALTH; RABIES; TUBERCULOSIS;

EID: 84866066769     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0373     Document Type: Article

References (38)

1. Mulhall, M. G. 1892 Dictionary of statistics. London, UK: George Routledge.
2. Harvard University Library. 2011 Contagion: historical views of diseases and epidemics. The President and Fellows of Harvard College. See http://ocp.hul.harvard.edu/contagion/sanitaryconferences.html.
3. Hamlin, C. & Sheard, S. 1998 Revolutions in public health: 1848, and 1998? Br. Med. J. 317, 587-591. (doi:10.1136/bmj.317.7158.587)
4. Bartram, J. & Cairncross, S. 2010 Hygiene, sanitation, and water: forgotten foundations of health. PLoS Med. 7, e1000367. (doi:10.1371/journal.pmed.1000367)
5. Mutreja, A. et al. 2011 Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477, 462-465. (doi:10.1038/nature10392)
6. Bhattacharya, S. et al. 2009 Public health. The cholera crisis in Africa. Science 324, 885. (doi:10.1126/science.1173890)
7. Centers for Disease Control and Prevention. 2010 Update: cholera outbreak-Haiti, 2010. Morb. Mortal. Wkly Rep. 59, 1473-1508.
8. Chin, C. S. et al. 2011 The origin of the Haitian cholera outbreak strain. N Engl. J. Med. 364, 33-42. (doi:10.1056/NEJMoa1012928)
9. WHO. 1997 Collaborating Centre for Rabies Surveillance and Research.Rabies Bull. Eur. 4, 21.
10. Dye, C. 1998 Risk assessment. In Quarantine and rabies: a reappraisal (ed. I. Kennedy), p. 315. London, UK: Ministry of Agriculture, Fisheries and Food.
11. World Health Organization. 2010 M/XDR-TB surveillance and response: 2010 global update. Geneva, Switzerland: World Health Organization.
12. Centers for Disease Control and Prevention. 2006 Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. Morb. Mortal. Wkly Rep. 55, 301-305.
13. Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., van Soolingen, D., Jensen, P. & Bayona, J. 2010 Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375, 1830-1843. (doi:10.1016/S0140-6736(10)60410-2)
14. Gandhi, N. R., Moll, A., Sturm, A. W, Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J. & Friedland, G. 2006 Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis in a rural area of South Africa. Lancet 368, 1575-1580. (doi:10.1016/S0140-6736(06)69573-1)
15. Centers for Disease Control and Prevention and National Jewish Medical and Research Center. 2007 Press briefing transcripts: update on tuberculosis case in an international traveler, Atlanta. See www.cdc.gov/media/transcripts/2007/t070703.htm.
16. Loveday, M., Thomson, L., Chopra, M. & Ndlela, Z. 2008 A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. Int. J. Tuberc. Lung Dis. 12, 1042-1047.
17. Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., Ziazarifi, A. H. & Hoffner, S. E. 2009 Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136, 420-425. (doi:10.1378/chest.08-2427)
18. Dye, C. 2009 Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat. Rev. Microbiol. 10, 81-87. (doi:10.1038/nrmicro2048)
19. Dye, C. & Williams, B. G. 2009 Slow elimination of multidrug-resistant tuberculosis. Sci. Transl. Med. 1, 3ra8. (doi:10.1126/scitranslmed.3000346)
20. World Health Organization, Stop TB Partnership. 2010 The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. Geneva, Switzerland: World Health Organization.
21. Singh, J. A., Upshur, R. & Padayatchi, N. 2007 XDR-TB in South Africa: no time for denial or complacency. PLoS Med. 4, e50. (doi:10.1371/journal.pmed.0040050)
22. Goemaere, E., Ford, N., Berman, D., McDermid, C. & Cohen, R. 2007 XDR-TB in South Africa: detention is not the priority. PLoS Med. 4, e162. (doi:10.1371/journal.pmed.0040162)
23. Ho, D. D. 1995 Time to hit HIV, early and hard. N. Engl. J. Med. 333, 450-451. (doi:10.1056/NEJM199508173330710)
24. Gulick, R. M. 2010 Antiretroviral treatment 2010: progress and controversies. J. Acquir. Immune Defic. Syndr. 55(Suppl 1), S43-S48. (doi:10.1097/QAI.0b013e3181f9c09e)
25. UNAIDS. 2010 Report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS.
26. Montaner, J. S., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R. & Harrigan, P R. 2006 The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368, 531-536. (doi:10.1016/S0140-6736(06)69162-9)
27. Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M. & Williams, B. G. 2009 Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373, 48-57. (doi:10.1016/S0140-6736(08)61697-9)
28. Williams, B. G. & Dye, C. 2003 Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301, 1535-1537. (doi:10.1126/science.1086845)
29. Williams, B. G., Granich, R., De Cock, K. M., Glaziou, P., Sharma, A. & Dye, C. 2010 Antiretroviral therapy for tuberculosis control in nine African countries. Proc. Natl Acad. Sci. USA 107, 19485-19489. (doi:10.1073/pnas.1005660107)
30. World Health Organization. 2010 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva, Switzerland: World Health Organization.
31. World Health Organization. 2011 International Health Regulations (IHR). See http://www.who.int/topics/international_health_regulations/en/.
32. Barnett, D. J., Omer, S. B., Fidler, D. P., Balicer, R. D. & Hodge Jr, J. G. 2007 Global triage of global resources needed. Br. Med. J. 334, 1071. (doi:10.1136/bmj.39220.443889.3A)
33. Martin, R. et al. 2010 Pandemic influenza control in Europe and the constraints resulting from incoherent public health laws. BMC Public Health 10, 532. (doi:10.1186/1471-2458-10-532)
34. Ricks, D. 2010 The intellectual property fight that could kill millions. Discover Magazine. 28 January 2010 See http://discovermagazine.com/.
35. Kaufmann, S. H. 2010 Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 33, 567-577. (doi:10.1016/j.immuni.2010.09.015)
36. McKinnon, L. R. & Card, C. M. 2010 HIV vaccine efficacy trials: a brief history, and options for going forward. AIDS Rev. 12, 209-217.
37. Kim, J. H., Rerks-Ngarm, S., Excler, J. L. & Michael, N. L. 2010 HIV vaccines: lessons learned and the way forward. Curr. Opin. HIV AIDS 5, 428-434. (doi:10.1097/COH.0b013e32833d17ac)
38. Birch, M. 2009 Implementing equity: the commission on social determinants of health. Bull. World Health Organ. 87, 3. (doi:10.2471/BLT.08.061978)